Home > Drug List > Cobimetinib > Indications of Cobimetinib

Indications of Cobimetinib

Unresectable or Metastatic MelanomaCobimetinib® is indicated for use in combination with vemurafenib for the treatment of adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations.

Histiocytic NeoplasmsCobimetinib® is indicated as monotherapy for the treatment of adult patients with histiocytic neoplasms.

FDA,2023.05

Recommended Articles

Related Articles

  • Cobimetinib(Cotellic)

    This product is indicated for the treatment of adult patients with unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations (in combination with vemurafenib), as···【more】
    Article source:Lucius LaosRelease date:2026-01-05Recommended:9

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

Lucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved

WhatsApp